Cargando…
Molecular modeling of antibodies for the treatment of TNF α‐related immunological diseases
Therapeutic monoclonal antibodies (mAbs) have high efficacy in treating TNF α‐related immunological diseases. Other than neutralizing TNF α, these IgG1 antibodies exert Fc receptor‐mediated effector functions such as the complement‐dependent cytotoxicity (CDC) and antibody‐dependent cell cytotoxicit...
Autores principales: | Pierri, Ciro Leonardo, Bossis, Fabrizio, Punzi, Giuseppe, De Grassi, Anna, Cetrone, Michela, Parisi, Giovanni, Tricarico, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777268/ https://www.ncbi.nlm.nih.gov/pubmed/26977294 http://dx.doi.org/10.1002/prp2.197 |
Ejemplares similares
-
Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle
por: Mele, Antonietta, et al.
Publicado: (2014) -
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies
por: Mercurio, Ivan, et al.
Publicado: (2020) -
Zoledronic Acid as a Novel Dual Blocker of KIR6.1/2-SUR2 Subunits of ATP-Sensitive K(+) Channels: Role in the Adverse Drug Reactions
por: Maqoud, Fatima, et al.
Publicado: (2021) -
Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFα therapy
por: Aita, Ada, et al.
Publicado: (2018) -
Anti-TNF-α therapy in membranous glomerulonephritis
por: Santoro, Domenico, et al.
Publicado: (2012)